Format

Send to

Choose Destination
Haematologica. 2018 Dec 13. pii: haematol.2018.207027. doi: 10.3324/haematol.2018.207027. [Epub ahead of print]

New molecular and therapeutic insights into canine diffuse large B cell lymphoma elucidates the role of the dog as a model for human disease.

Author information

1
Dipartimento di Scienze Veterinarie, Università degli Studi di Torino, Torino, Italy.
2
Dipartimento di Biomedicina Comparata e Alimentazione, Università degli Studi di Padova,Italy.
3
Centro Oncologico Veterinario, Sasso Marconi, Italy.
4
Universita' della Svizzera italiana, Institute of Oncology Research (IOR), Bellinzona, Switzerland.
5
Institute of Oncology Research (IOR), Bellinzona, Switzerland.
6
Div. of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, UK.
7
PIQUR Therapeutics AG, Basel, Switzerland.
8
Department of Biomedicine, University of Basel, Basel, Switzerland.
9
Dipartimento di Medicina Veterinaria, Università degli Studi di Milano, Milano, Italy.
10
Institute of Oncology Research (IOR), Bellinzona, Switzerland; frbertoni@mac.com.

KEYWORDS:

Aggressive Non-Hodgkin's Lymphoma; BET bromodomain; MYC; comparative oncology; immune checkpoint

PMID:
30545928
DOI:
10.3324/haematol.2018.207027
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center